Skip to main content
Clinical Trials/NCT00186147
NCT00186147
Enrolling By Invitation
Not Applicable

Bone Marrow Grafting for Leukemia and Lymphoma

Stanford University1 site in 1 country9,999 target enrollmentSeptember 16, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Leukemia
Sponsor
Stanford University
Enrollment
9999
Locations
1
Primary Endpoint
Identify and characterize proteins and genes that may contribute to the development and progression of cancer.
Status
Enrolling By Invitation
Last Updated
4 months ago

Overview

Brief Summary

The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.

Detailed Description

The purpose of this study is to acquire critical tissue and biological samples that can be evaluated to elucidate underlying mechanisms of disease control, transplant related complications and overall outcomes

Registry
clinicaltrials.gov
Start Date
September 16, 2005
End Date
December 1, 2069
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All hematopoietic cell transplant recipients and donors who agree to participate

Exclusion Criteria

  • Subject does not agree to participate

Outcomes

Primary Outcomes

Identify and characterize proteins and genes that may contribute to the development and progression of cancer.

Time Frame: blood sample is collected prior transplant, periodically during the first three months and then indefinately at follow up

Study Sites (1)

Loading locations...

Similar Trials